Sensei Biotherapeutics (SNSE) Institutional Ownership → This is the best new way to score with AI (From Weiss Ratings) (Ad) Free SNSE Stock Alerts $1.59 +0.10 (+6.71%) (As of 04:28 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability Institutional Ownership Changes (13F Filings) for Sensei Biotherapeutics (NASDAQ:SNSE)CurrentInstitutional OwnershipPercentage10.50%Number ofInstitutional Buyers(last 12 months)0Number ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$21.79K Get SNSE Insider Trade Alerts Want to know when executives and insiders are buying or selling Sensei Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data SNSE Institutional Buying and Selling by Quarter Ad Manward PressThe most important AI company you've never heard ofBecause this small company solves the BIGGEST problem with Nvidia's AI chips. Already, Amazon, Microsoft, Google and others are lining up to get this company's products.Get the full story on this secret AI company poised for massive growth Sensei Biotherapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/14/2023Newtyn Management LLC1,800,000$1.35M0.3%-1.5%7.200% 11/14/2022RA Capital Management L.P.683,529$1.06M0.0%-5.5%2.225% 7/22/2022 Truist Financial Corp19,934$45K0.0%-60.5%0.065% 5/3/2022Leo Brokerage LLC14,845$34K0.0%N/A0.048% 11/16/2021Millennium Management LLC258,659$2.72M0.0%N/A0.846% 11/16/2021Moore Capital Management LP49,341$519K0.0%-61.3%0.161% Get the Latest News and Ratings for SNSE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sensei Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/12/2021 Tao Capital Management LP32,784$345K0.1%N/A0.107% 11/12/2021 The Manufacturers Life Insurance Company13,478$142K0.0%N/A0.044% 11/12/2021 Geode Capital Management LLC273,978$2.88M0.0%+93.2%0.896% 11/10/2021 Citigroup Inc.2,409$25K0.0%+565.5%0.008% 11/9/2021 BlackRock Inc.1,000,322$10.52M0.0%+175.2%3.270% 11/5/2021 Truist Financial Corp70,374$740K0.0%N/A0.230% 11/4/2021Deutsche Bank AG12,021$126K0.0%+158.3%0.039% 11/1/2021 SG Americas Securities LLC12,614$133K0.0%N/A0.041% 10/13/2021BFT Financial Group LLC14,845$156K0.0%N/A0.049% 8/17/2021Citadel Advisors LLC283,667$2.77M0.0%-59.0%0.927% 8/16/2021Alyeska Investment Group L.P.40,000$390K0.0%N/A0.131% 8/16/2021Tudor Investment Corp Et Al28,111$274K0.0%-75.2%0.092% 8/16/2021 Charles Schwab Investment Management Inc.54,965$537K0.0%+18.9%0.180% 8/16/2021State Street Corp100,000$976K0.0%+70.2%0.327% 8/13/2021 Formula Growth Ltd.100,000$976K0.1%+77.7%0.327% 8/13/2021 Northern Trust Corp75,011$733K0.0%-8.5%0.245% 8/13/2021 Geode Capital Management LLC141,809$1.38M0.0%+20.8%0.464% 8/13/2021 Vanguard Group Inc.387,753$3.78M0.0%+19.4%1.268% 8/12/2021 JPMorgan Chase & Co.179,078$1.75M0.0%+15.1%0.585% 8/11/2021 Bank of New York Mellon Corp18,431$180K0.0%+31.1%0.060% 8/11/2021 BlackRock Inc.363,466$3.55M0.0%+9.2%1.188% 8/11/2021Deutsche Bank AG4,653$45K0.0%-73.3%0.015% 8/2/2021 New York State Common Retirement Fund5,396$53K0.0%+37.2%0.018% 5/27/2021Davidson Kempner Capital Management LP26,000$376K0.0%N/A0.085% 5/21/2021Citadel Advisors LLC692,537$10.06M0.0%N/A2.264% 5/18/2021Zimmer Partners LP46,000$668K0.0%N/A0.150% 5/18/2021Tudor Investment Corp Et Al113,353$1.65M0.0%N/A0.371% 5/18/2021Duquesne Family Office LLC100,000$1.45M0.0%N/A0.327% 5/18/2021Davidson Kempner Capital Management LP26,000$376K0.0%N/A0.085% 5/18/2021Citadel Advisors LLC692,537$10.06M0.0%N/A2.264% 5/18/2021 Falcon Edge Capital LP213,658$3.10M0.2%N/A0.699% 5/18/2021California State Teachers Retirement System11,494$167K0.0%N/A0.038% 5/17/2021Deerfield Management Company L.P. Series C375,000$5.45M0.1%N/A1.226% 5/17/2021 Nuveen Asset Management LLC12,340$179K0.0%N/A0.040% Tiny AI projects with huge promise hiding in plain sight … (Ad)I’ve developed a system that’s helped me find huge winners in the past. Now my system has alerted me to the next four altcoins that could be the next superstars.Click here to find out who they are.5/13/2021 Bank of New York Mellon Corp14,062$205K0.0%N/A0.046% 5/12/2021Serengeti Asset Management LP20,000$291K0.1%N/A0.065% 5/12/2021 Northern Trust Corp81,947$1.19M0.0%N/A0.268% 5/12/2021 Geode Capital Management LLC117,406$1.71M0.0%N/A0.384% 5/12/2021Pura Vida Investments LLC67,357$941K0.0%N/A0.220% 5/12/2021 JPMorgan Chase & Co.155,647$2.26M0.0%N/A0.509% 5/12/2021 UBS Group AG2,099$31K0.0%N/A0.007% 5/11/2021 New York State Common Retirement Fund3,934$57K0.0%N/A0.013% 5/7/2021 BlackRock Inc.332,700$4.83M0.0%N/A1.088% 5/7/2021 American International Group Inc.4,441$65K0.0%N/A0.015% (Data available from 1/1/2016 forward) SNSE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SNSE shares? During the previous two years, the following institutional investors and hedge funds held shares of Sensei Biotherapeutics shares: Newtyn Management LLC ($1.35M), and RA Capital Management L.P. ($1.06M), Truist Financial Corp ($45K).Learn more on SNSE's institutional investors. What percentage of Sensei Biotherapeutics stock is owned by institutional investors? 10.50% of Sensei Biotherapeutics stock is owned by institutional investors. Learn more on SNSE's institutional investor holdings. Which Sensei Biotherapeutics major shareholders have been selling company stock? The following institutional investors have sold Sensei Biotherapeutics stock in the last 24 months: RA Capital Management L.P. ($40.02K), Truist Financial Corp ($30.51K), and Newtyn Management LLC ($27.24K). How much institutional selling is happening at Sensei Biotherapeutics? Institutional investors have sold a total of 97,767 shares in the last 24 months. This volume of shares sold represents approximately $153.07K in transactions. Related Companies: IMRX Major Shareholders XLO Major Shareholders LEXX Major Shareholders NXTC Major Shareholders UNCY Major Shareholders CARA Major Shareholders RMTI Major Shareholders HCWB Major Shareholders EYEN Major Shareholders BOLT Major Shareholders This page (NASDAQ:SNSE) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden to Drop BOMBSHELL June 13th?Paradigm PressElon to Transform U.S. Economy? Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityThe most important AI company you've never heard ofManward PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon’s New Device is About to Shock the WorldInvestorPlaceGold ManiaStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sensei Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
